Nurix Therapeutics Ownership | Who Owns Nurix Therapeutics?
Nurix Therapeutics Ownership Summary
Nurix Therapeutics is owned by 105.27% institutional investors, 1.43% insiders. Fmr is the largest institutional shareholder, holding 14.61% of NRIX shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 3.16% of its assets in Nurix Therapeutics shares.
NRIX Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Nurix Therapeutics | 105.27% | 1.43% | -6.70% |
| Sector | Healthcare Stocks | 488.17% | 11.08% | -399.26% |
| Industry | Biotech Stocks | 306.59% | 11.10% | -217.69% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Fmr | 10.63M | 14.61% | $200.35M |
| Blackrock | 6.82M | 12.42% | $142.33M |
| Blackrock funding, inc. /de | 6.81M | 8.12% | $77.55M |
| Deep track capital, lp | 6.06M | 7.23% | $69.08M |
| Vanguard group | 4.35M | 5.97% | $81.86M |
| State street | 2.71M | 4.93% | $56.53M |
| Wellington management group llp | 3.59M | 4.93% | $67.57M |
| Baker bros. advisors lp | 3.88M | 4.63% | $44.22M |
| Redmile group | 3.73M | 4.45% | $42.52M |
| Point72 asset management | 3.70M | 4.42% | $42.18M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Redmile group | 3.73M | 4.53% | $42.52M |
| Commodore capital lp | 3.00M | 4.14% | $56.52M |
| Deep track capital, lp | 6.06M | 2.22% | $69.08M |
| Soleus capital management | 2.42M | 1.83% | $27.60M |
| Patient square capital lp | 412.30K | 1.69% | $4.70M |
| Affinity asset advisors | 967.62K | 1.51% | $11.02M |
| Kynam capital management, lp | 1.17M | 1.44% | $13.37M |
| Vestal point capital, lp | 2.00M | 1.20% | $22.78M |
| Vienna powszechne towarzystwo emerytalne s.a. vienna insurance group | 85.00K | 0.61% | $968.15K |
| Westhill financial advisors | 228.33K | 0.55% | $2.60M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Fmr | 10.63M | 0.01% | 10.05M |
| Point72 asset management | 3.70M | 0.08% | 3.49M |
| Blackrock | 6.82M | 0.00% | 2.24M |
| Commodore capital lp | 3.00M | 4.14% | 1.35M |
| Vestal point capital, lp | 2.00M | 1.20% | 874.45K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Ra capital management | - | - | -1.33M |
| Blackrock funding, inc. /de | 6.81M | 0.00% | -1.18M |
| Bain capital life sciences investors | - | - | -1.13M |
| Driehaus capital management | - | - | -715.94K |
| Morgan stanley | 1.99M | 0.00% | -541.10K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Norges bank | 318.80K | 0.00% | 318.80K | $6.01M |
| Polar asset management partners | 154.40K | 0.03% | 154.40K | $1.76M |
| Bollard group | 122.78K | 0.03% | 122.78K | $1.40M |
| Algert global | 114.50K | 0.03% | 114.50K | $1.30M |
| Baird financial group | 110.00K | 0.00% | 110.00K | $1.25M |
Sold Out
| Holder | Change |
|---|---|
| True wealth design | -4.00 |
| Ifp advisors | -6.00 |
| Nelson, van denburg & campbell wealth management group | -9.00 |
| Federated hermes | -15.00 |
| Amundi | -17.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2025 | 164 | -4.09% | 88,304,128 | 5.07% | 105 | 1.04% | 91 | -3.19% | 42 | -17.65% |
| Mar 31, 2025 | 171 | -3.93% | 84,588,676 | 4.29% | 101 | 0.69% | 93 | -11.43% | 51 | 10.87% |
| Dec 31, 2024 | 177 | 1.72% | 81,111,271 | 20.04% | 120 | 1.40% | 103 | 9.57% | 47 | -16.07% |
| Sep 30, 2024 | 174 | -1.14% | 67,568,477 | 3.95% | 92 | 0.66% | 94 | -16.81% | 56 | 24.44% |
| Jun 30, 2024 | 175 | 24.11% | 64,997,079 | 32.92% | 118 | 1.49% | 112 | 60.00% | 45 | 4.65% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 2.42M | 3.16% | -53.57K |
| Vanguard US Total Market Shares ETF | 2.13M | 2.79% | 196.50K |
| iShares Russell 2000 ETF | 1.78M | 2.33% | -33.81K |
| Fidelity Select Health Care | 1.60M | 2.09% | - |
| ARK Genomic Revolution | 1.54M | 2.01% | -28.29K |
| ARK Genomic Revolution ETF | 1.52M | 1.99% | -9.12K |
| Amova ARK Pstv Chg Innovt P JPY Acc | 1.42M | 1.86% | 322.21K |
| T. Rowe Price New Horizons | 1.35M | 1.76% | -6.71K |
| US Small-Cap Growth II Equity Comp | 1.35M | 1.76% | 14.21K |
| Nikko AM ARK Pstv Chg Innovt P JPY Acc | 1.10M | 1.44% | 273.18K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Aug 01, 2025 | van Houte Hans | Chief Financial Officer | Sell | $59.60K |
| Jul 30, 2025 | van Houte Hans | Chief Financial Officer | Sell | $51.70K |
| Jul 30, 2025 | Ring Christine | Chief Legal Officer | Sell | $46.13K |
| Jul 30, 2025 | Hansen Gwenn | Chief Scientific Officer | Sell | $51.74K |
| May 02, 2025 | van Houte Hans | Chief Financial Officer | Sell | $70.24K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q3 | - | 4 |
| 2025 Q2 | - | 4 |
| 2025 Q1 | - | 11 |
| 2024 Q4 | - | 10 |
| 2024 Q3 | - | 13 |
NRIX Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools